Law360, New York (January 18, 2011, 8:21 PM ET) -- A federal judge has greenlighted several suits against Abbott Laboratories accusing the pharmaceutical company of illegally hiking the price for its HIV drug Norvir in order to protect another Abbott drug from competition, setting the stage for a jury trial.
Judge Claudia Wilken of the U.S. District Court for the Northern District of California on Friday denied parts of a motion for summary judgment from the plaintiffs — a group that includes direct purchasers Safeway Inc. and Walgreen Co. as well as Abbott competitor SmithKline Beecham...
Judge Sets Stage For Trial In Norvir Monopoly Case
To view the full article, take a free trial now.
